Observational group (no intervention) clinical trials

A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer

This study looks at a new drug, RO7198457, for people in the UK with certain types of bowel cancer (colorectal cancer) that's been removed by surgery. It compares the drug to just watching to see if the cancer comes back.